Park, J., Jeongs, S., Yu, J., Kim, G., Jeong, L. S., & Oh, G. T. (2018). LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice. BMB Rep.

Park, Jong-Gil, Se-Jin Jeongs, Jinha Yu, Gyudong Kim, Lak Shin Jeong, and Goo Taeg Oh. "LJ-1888, a Selective Antagonist for the A3 Adenosine Receptor, Ameliorates the Development of Atherosclerosis and Hypercholesterolemia in Apolipoprotein E Knock-out Mice." BMB Rep 2018.

Park, Jong-Gil, et al. "LJ-1888, a Selective Antagonist for the A3 Adenosine Receptor, Ameliorates the Development of Atherosclerosis and Hypercholesterolemia in Apolipoprotein E Knock-out Mice." BMB Rep 2018.